ALTEOGEN INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,59,500 KRW | +1.76% |
|
-5.98% | +163.45% |
| 2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
| 2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 980.69Cr | ||||||
| 9.45TCr | ||||||
| 3.89TCr | ||||||
| 3.26TCr | ||||||
| 1.6TCr | ||||||
| 1.38TCr |
- Stock Market
- Equities
- A196170 Stock
- Charts ALTEOGEN Inc.
- Sector Chart
